Platform now available to pharmaceutical research partners; powers collaborations totaling over $200 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
After raising $33 million in just 15 seconds, Shivom has entered into partnership with SingularityNet, in order to combine blockchain, AI and genomic research in order to achieve advanced, ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and ...
WuXi NextCODE closed a $240 million Series B financing round. Sequoia China led the funding round. WuXi NextCODE is a global platform for genomic data. It will use the funds to extend platform ...
CHICAGO, IL, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Igenbio today announced that ERGO™ 2.0, its flagship ...
The initiative will be executed through a national genomic selection breeding consortium of public and private sector breeding organizations, led by the Global Institute for Food Security (GIFS) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback